TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Biorega AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
226
|
404
|
31 |
| Financial expenses |
27
|
0
|
1 |
| Earnings before taxes |
1,302
|
4,396
|
-10 |
| EBITDA |
-29
|
-139
|
-9 |
| Total assets |
4,273
|
5,557
|
1,393 |
| Current assets |
3,898
|
5,557
|
193 |
| Current liabilities |
76
|
442
|
661 |
| Equity capital |
4,177
|
5,102
|
724 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
97.8%
|
91.8%
|
52.0% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
576.1%
|
1088.1%
|
-32.3% |
| Return on assets (ROA) |
31.1%
|
79.1%
|
-0.6% |
| Current ratio |
5128.9%
|
1257.2%
|
29.2% |
| Return on equity (ROE) |
31.2%
|
86.2%
|
-1.4% |
| Change turnover |
-178
|
373
|
31 |
| Change turnover % |
-44%
|
1203% | |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.